News

Thumbnail

Treating certain high-risk PCI patients with nicorandil before and after treatment can significantly reduce their risk of contrast-related injuries.

robot reviewing heart data

“We have colonoscopies, we have mammograms, but we have not had equivalents for most forms of heart disease,”  Pierre Elias, MD, Pathway Labs founder and CEO, explained.

 Derek Pineda, FNP, CCRN, RCIS, FACC, with Mount Sinai Fuster Heart Hospital, explains the use of a digital app platform for STEMI team coordination that helped his health system improve STEMI outcomes.

One of the platform's biggest benefits is the rich clinical information it provides to all members of the care team.

radiology residents training

Harvard University is the No. 1 school in the world for radiology, nuclear medicine and medical imaging, according to the publication. 

Javier Villanueva-Meyer, MD ou health

Javier Villanueva-Meyer, MD, is slated to take on the title in September, also acting as clinical service chief of radiology at OU Health, the school’s academic hospital system. 

Akumin

The Tampa, Florida-based firm announced it’s teaming with CGS Premier to form a new company called Mobile Healthcare Innovations

UPMC Williamsport interventional radiology suite

UPMC Williamsport, a 224-bed acute care hospital, said the relocated IR facility seeks to bring minimally invasive care closer to home for patients in north central Pennsylvania

Nurses and AI artificial intelligence

New academic research analyzing data from the National Sample Survey of Registered Nurses drills down into nurses’ self-reported “turnover behaviors.” 

the words "FDA recall" on a board

The Class 2 recall pertains to the system's built-in shielding and collimation accessories. 

Abbott's Navitor TAVR valve

Abbott's TAVR valve now has CE mark approval for treating low-, intermediate- and high-risk patients who present with symptomatic severe aortic stenosis. The news comes as new data on the valve's safety and effectiveness were just published in JACC: Cardiovascular Interventions.

Recor Medical's Paradise Ultrasound Renal Denervation System

Recor Medical's Paradise Ultrasound Renal Denervation System is the first medical device approved for the treatment of hypertension in Japan. It first gained FDA approval back in 2023.

Thumbnail

Leqembi (lecanemab) was approved by the FDA in 2023. It is an infusion drug that has been shown to reduce Alzheimer’s-related cognitive decline by up to 27%. 

Around the web

Treating certain high-risk PCI patients with nicorandil before and after treatment can significantly reduce their risk of contrast-related injuries.

“We have colonoscopies, we have mammograms, but we have not had equivalents for most forms of heart disease,”  Pierre Elias, MD, Pathway Labs founder and CEO, explained.

One of the platform's biggest benefits is the rich clinical information it provides to all members of the care team.